Roland Landman MD, he is based on the Infectious Diseases Division of the Department of Infectious and Tropical Diseases, Bichat Hospital, Paris, France. He is the head of HIV clinical research of the Institut of Medicine and Epidemiology (IMEA) in Paris and principal investigator of several clinical trials both in France and West Africa on antiretroviral drugs strategy, simplification and adherence. He coordinates the ANRS ((French National Agency for Research on AIDS and Viral Hepatitis) working group on simplification ARV strategy. He’s the actual principal investigator in ANRS clinical trial: THILAO trial on a third line regimen in five sub-Saharan African countries, MODERATO trial of dual antiretroviral therapy for maintenance therapy in four sub-Saharan African countries and QUATUOR trial of 4 days a week antiretroval maintenance therapy in France.
He was an associated professor at the University of Minnesota, Minneapolis (200-2005) Division of Epidemiology “International Health: Control of Infectious Diseases”. He’s associated researcher at IAME, Inserm UMR 1137, Université Paris 7.
He worked as a senior physician and follows HIV/AIDS patients since 1987. He’s responsible for patient database for the cohort of 5200 HIV / AIDS infected patients in the infectious diseases department of Bichat Hospital Claude Bernard and assume the coordination of clinical research in the department
Dr. Deborah Konopnicki
Deborah Konopnicki is an internal medicine and infectious disease specialist graduated from
the Université Libre de Bruxelles in 2000. She has been working in Saint-Pierre University
Hospital in Brussels since 1997 and is now senior physician in the Infectious diseases
Department and AIDS Reference Center.
In June 2014, she presented her PhD on Infection with high risk Human Papillomavirus
(HRHPV) among HIV-positive women: epidemiology, natural history and impact of combined
antiretroviral therapy. She is particularly involved in care for women living with HIV.
Dr. Rolf Kaiser
Rolf Kaiser studied Biology in Bonn, Germany. His PhD was about molecular biological investigations of the Cystic Fibrosis gene which was finished in 1990.
In 1990 he started investigating viruses in the Institute of Medical Microbiology and Immunology, University Clinics of Bonn. Diagnostic and scientific activities included all clinical relevant viruses, mainly to improve the diagnostics of those viruses. But the scientific focus was on Hepatitis viruses (HBV, HCV) and on HIV, especially on transmission chains of HIV and HCV.
Changing to the Institute of Virology of the University Clinics of Cologne in 1999 resulted in a focus on HIV resistance during the first years. One of the fruitful outcomes of this period was the geno2pheno resistance interpretation system for HIV. Geno2pheno is a result of the interdisciplinary cooperation between clinicians, bioinformaticions and virologists. Initiated in 1998, the originally single tool that was made to predict phenotypic resistance from the generated HIV-sequence in HIV Protease and RT extended meanwhile to a whole family of tools to predict HIV tropism, Integrase resistance, HCV resistance and genotyping as well as HBV resistance and immune escape. On a European level we created the EUResist project, which contains the world’s largest dataset of HIV sequences and resistance data. He EUResist project started under the coordination of our Italian partners with the help of our Swedish partners and with IBM Haifa. Today further European partners joined and demonstrate the EUResist project to be living and dynamic project with a great future